Drug intelligence / Profile preview

Redox Support Formula

Development stage: Unknown
Lead developer: Ethos Research & Development
Administration: Oral

Overview

Redox Support Formula is a dietary supplement developed by Ethos Research & Development. It is a combination of N-Acetyl-L-Cysteine, CoQ10, Acetyl-L-Carnitine, Alpha Lipoic Acid, Benfotiamine, Selenium, Riboflavin, Zinc, and Copper. This formula is specifically designed to address oxidative stress and support redox balance. It is being investigated in a pilot study to assess its impact on quality of life and urinary biomarker scores in patients experiencing chronic pain.

Targets

Misfolded SOD1ND1 (Mitochondrial electron transport chain complex I)GSH (Glutathione)GPX4 (Glutathione peroxidase 4)Neuraminidase

Beyond the preview

Go deeper on Redox Support Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redox Support Formula.

Explore the full profile